Vanda Pharmaceuticals Inc.
Key Metrics
- Previous Close
- $3.81
- 52-Week Range
- $3.57 – $9.94
- Market Cap
- $226.76M
- P/E (TTM)
- —
- EPS (TTM)
- -4.62
- Dividend Yield
- 0.00%
Advanced Metrics
- Price/Book
- 1.13
- PEG Ratio
- 2.23
- Return on Equity
- -82.55%
- Return on Assets
- -22.61%
- Gross Margin
- 93.59%
- Operating Margin
- -77.59%
- Profit Margin
- -119.87%
- Current Ratio
- 1.54
- Debt/Equity
- 0.11
- Total Debt
- $21.97M
- Free Cash Flow
- $-85.87M
- Revenue Growth
- 24.10%
- Earnings Growth
- —
- Enterprise Value
- $108.24M
Market Snapshot
About
Vanda Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of therapies for central nervous system disorders. The company markets treatments for conditions including non-24-hour sleep-wake disorder and nighttime sleep disturbances in totally blind individuals.